Bluejay Diagnostics (BJDX) Competitors $1.41 -0.05 (-3.42%) Closing price 04:00 PM EasternExtended Trading$1.41 +0.00 (+0.28%) As of 07:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BJDX vs. HSCS, STSS, SSKN, HSDT, LUCY, AMIX, GCTK, NUWE, XAGE, and QNRXShould you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include HeartSciences (HSCS), Sharps Technology (STSS), Strata Skin Sciences (SSKN), Helius Medical Technologies (HSDT), Innovative Eyewear (LUCY), Autonomix Medical (AMIX), GlucoTrack (GCTK), Nuwellis (NUWE), Longevity Health (XAGE), and Quoin Pharmaceuticals (QNRX). These companies are all part of the "medical equipment" industry. Bluejay Diagnostics vs. Its Competitors HeartSciences Sharps Technology Strata Skin Sciences Helius Medical Technologies Innovative Eyewear Autonomix Medical GlucoTrack Nuwellis Longevity Health Quoin Pharmaceuticals Bluejay Diagnostics (NASDAQ:BJDX) and HeartSciences (NASDAQ:HSCS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, media sentiment, profitability and dividends. Does the media favor BJDX or HSCS? In the previous week, Bluejay Diagnostics had 1 more articles in the media than HeartSciences. MarketBeat recorded 2 mentions for Bluejay Diagnostics and 1 mentions for HeartSciences. Bluejay Diagnostics' average media sentiment score of -1.00 equaled HeartSciences'average media sentiment score. Company Overall Sentiment Bluejay Diagnostics Negative HeartSciences Negative Which has preferable valuation and earnings, BJDX or HSCS? Bluejay Diagnostics has higher revenue and earnings than HeartSciences. HeartSciences is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBluejay Diagnostics$250K8.40-$7.72M-$125.15-0.01HeartSciencesN/AN/A-$8.77M-$9.36-0.36 Which has more risk & volatility, BJDX or HSCS? Bluejay Diagnostics has a beta of 0.48, meaning that its share price is 52% less volatile than the S&P 500. Comparatively, HeartSciences has a beta of 2.57, meaning that its share price is 157% more volatile than the S&P 500. Do insiders and institutionals believe in BJDX or HSCS? 18.5% of Bluejay Diagnostics shares are held by institutional investors. Comparatively, 17.2% of HeartSciences shares are held by institutional investors. 0.1% of Bluejay Diagnostics shares are held by company insiders. Comparatively, 1.8% of HeartSciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is BJDX or HSCS more profitable? HeartSciences' return on equity of -293.60% beat Bluejay Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Bluejay DiagnosticsN/A -362.07% -299.10% HeartSciences N/A -293.60%-135.39% Do analysts prefer BJDX or HSCS? HeartSciences has a consensus price target of $13.00, suggesting a potential upside of 290.39%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts clearly believe HeartSciences is more favorable than Bluejay Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bluejay Diagnostics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00HeartSciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryHeartSciences beats Bluejay Diagnostics on 8 of the 13 factors compared between the two stocks. Get Bluejay Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BJDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BJDX vs. The Competition Export to ExcelMetricBluejay DiagnosticsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.18M$6.90B$5.75B$9.85BDividend YieldN/A1.22%6.67%4.51%P/E Ratio-0.0126.0678.4326.42Price / Sales8.4070.07546.94119.09Price / CashN/A21.6037.0558.92Price / Book0.144.9010.916.06Net Income-$7.72M$178.27M$3.29B$266.28M7 Day Performance2.92%-0.61%0.01%-0.76%1 Month Performance-5.69%1.88%7.06%3.83%1 Year Performance-81.81%9.93%50.09%24.39% Bluejay Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BJDXBluejay Diagnostics0.2385 of 5 stars$1.41-3.4%N/A-82.0%$2.18M$250K-0.019News CoverageNegative NewsShort Interest ↑Gap DownHSCSHeartSciences2.1806 of 5 stars$3.35-8.2%$13.00+288.1%+6.5%$8.31MN/A-0.3610Upcoming EarningsShort Interest ↑STSSSharps Technology0.8461 of 5 stars$10.35+40.6%N/AN/A$7.53MN/A-0.013Short Interest ↑Gap UpHigh Trading VolumeSSKNStrata Skin Sciences3.4085 of 5 stars$1.73-1.1%$6.00+246.8%-40.7%$7.30M$33.56M-0.61120News CoverageGap DownHSDTHelius Medical Technologies1.0613 of 5 stars$6.22-2.5%N/A-99.1%$6.87M$295K0.0030Positive NewsShort Interest ↓LUCYInnovative EyewearN/A$1.98-0.5%N/A-57.8%$6.56M$1.64M-0.719Gap DownAMIXAutonomix Medical3.1633 of 5 stars$1.02+1.0%$16.50+1,517.6%-91.9%$5.20MN/A-0.181News CoverageShort Interest ↓Gap DownGCTKGlucoTrack1.2685 of 5 stars$4.87-11.9%N/A-99.8%$4.97MN/A-0.095Short Interest ↓High Trading VolumeNUWENuwellis2.2803 of 5 stars$5.28+1.1%N/A-91.0%$4.71M$8.74M-0.1570Positive NewsShort Interest ↓Gap DownXAGELongevity HealthN/A$2.70+3.4%N/AN/A$4.65M$50K0.0014QNRXQuoin Pharmaceuticals1.328 of 5 stars$7.40+2.8%N/A-67.5%$4.24MN/A-0.184Short Interest ↓ Related Companies and Tools Related Companies HeartSciences Alternatives Sharps Technology Alternatives Strata Skin Sciences Alternatives Helius Medical Technologies Alternatives Innovative Eyewear Alternatives Autonomix Medical Alternatives GlucoTrack Alternatives Nuwellis Alternatives Longevity Health Alternatives Quoin Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BJDX) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bluejay Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bluejay Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.